Normalizing glucocorticoid levels attenuates metabolic and neuropathological symptoms in the R6/2 mouse model of huntington's disease
Huntington's disease (HD) is a fatal genetic neurological disorder caused by a mutation in the human Huntingtin (HTT) gene. This mutation confers a toxic gain of function of the encoded mutant huntingtin (mHTT) protein, leading to widespread neuropathology including the formation of mHTT-positi...
Main Authors: | Brett D. Dufour, Jodi L. McBride |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-01-01
|
Series: | Neurobiology of Disease |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0969996118302031 |
Similar Items
-
Prenatal corticosterone altered glucocorticoid receptor and glucocorticoid metabolic enzyme gene expression in chicken ovary
by: Abdelkareem A. Ahmed, et al.
Published: (2016-05-01) -
Huntingtin-Associated Protein 1 in Mouse Hypothalamus Stabilizes Glucocorticoid Receptor in Stress Response
by: Xingxing Chen, et al.
Published: (2020-06-01) -
Differential Phosphorylation of the Glucocorticoid Receptor in Hippocampal Subregions Induced by Contextual Fear Conditioning Training
by: Renata Ponce-Lina, et al.
Published: (2020-02-01) -
Glucocorticoids associate with cardiometabolic risk factors in black South Africans
by: Siphiwe N Dlamini, et al.
Published: (2021-08-01) -
Keratin Glucocorticoid Analysis by Enzyme Immunoassay in Mammals, Birds and Reptiles
by: Berkvens, Charlene N.
Published: (2012)